Although blocking of IL-1 or TNF-α has resulted in inconsistent results due to study design, recent clinical trials in stratified patients have shown IL-1- or TNF-blocking therapy to be effective in improving sepsis survival (14–16). The gene discussed is IL1A; the disease is Sepsis.